USA Today - New Multiple Sclerosis Medications Offer Options
The MS drug, Aubagio, was approved in September for general use — the second of a new generation of medications. For the first time, doctors and MS patients have a range of drugs to choose from. Twenty years ago, there were no drugs at all for MS, a disease in which the immune system attacks nerve cells in the brain and spinal cord, slowly robbing people of their physical coordination and mental sharpness. Now there are nine, with more on the way. "This has been the field that has seen the most dramatic therapeutic changes in all of neurology, and perhaps all of medicine, for the last 15 years, accelerating in the last few years," says Aaron E. Miller, MD, medical director of Mount Sinai School of Medicine's multiple sclerosis center.
- Dr. Aaron Miller, Professor, Neurology, Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai School of Medicine